Drugmaker Gilead is set to release clinical trial data in the next couple of weeks for a potential coronavirus treatment — the next big benchmark in a breakneck race to develop a drug that will help arrest the global pandemic.
Why it matters: The only way to truly get back to normal is through a treatment or, ideally, a vaccine. And the World Health Organization has said Gilead's drug, called remdesivir, is the "most promising candidate."
